Medicamen Organics IPO listing price is ₹ 144.70, issue price is ₹ 34.00, and currently trading at ₹ 45.15 as on June 12, 2025. Medicamen Organics IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Medicamen Organics IPO is a Book Building listing on NSE EMERGE exchange. The company is based in New Delhi and caters to Pharmaceutical sector. GYR Capital Advisors is the merchant banker of Medicamen Organics IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 21st February 2024.
Medicamen Organics IPO offer price is ₹ 34.00 and got listed at ₹ 144.70. Read Medicamen Organics IPO details mentioned above.The IPO of Medicamen Organics Limited was listed on 28th June 2024. As of today, Medicamen Organics IPO is trading at ₹ 45.15, compared to the previous day’s close of ₹ 44.30. Read the report above for detailed IPO performance.
The issue price of Medicamen Organics IPO was ₹ 34.00 per equity share.
Medicamen Organics IPO was listed at ₹144.70 on the stock exchange on 28th June 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 12, 2025, the current market price of Medicamen Organics IPO is ₹ 45.15.
The 52-week high for Medicamen Organics IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Medicamen Organics IPO listed at ₹ 144.70 against the issue price of ₹ 34.00 per equity share, showing a listing day gain/loss of 110.7 (325.59%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Medicamen Organics IPO stock moved from its listing price of ₹ 144.70 to the current price of ₹45.15 per equity share, reflecting a change of -68.80% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Medicamen Organics IPO issue date of 28th June 2024 and CMP of ₹45.15, the estimated CAGR is approximately 34.08%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Medicamen Organics IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Medicamen Organics Financial Review Page
Merchant Banker(s) of Medicamen Organics IPO: GYR Capital Advisors Private Limited
Medicamen Organics IPO subscription was 993.56 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Medicamen Organics IPO listed at a listing price of 144.70 against the offer price of 34.00.
The current market price of Medicamen Organics is 45.15.
Why Us?